Atlas Trials

Antiischemic Effects of Empagliflozin in Diabetic Patients With Refractory Angina

Clinical trial NCT04143321 · COMPLETED

Trial details

NCT number
NCT04143321
Sponsor
Isfahan University of Medical Sciences
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetes Mellitus
Start date
2018-09-10
Primary completion
2019-04-15
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.